Women receive more inpatient resections and ablations for hepatocellular carcinoma than men

Table 2 Multivariate logistic regression comparing outcomes of hepatocellular carcinoma by gender

Outcome	Gender	OR	95%CI	P value
Metastatic hepatocellular carcinoma1	Male	1.00	0.84, 1.05	0.303
	Female	0.94
Liver decompensation2	Male	1.00	0.77, 0.92	< 0.001
	Female	0.84
Inpatient mortality3	Male	1.00	0.65, 0.87	< 0.001
	Female	0.75

¹Model is adjusted for age, primary payer, hepatitis C, alcohol, non-alcoholic steatohepatitis (NASH), liver decompensation features, and Elixhauser comorbidity score;

²Model is adjusted for age, race, primary payer, geographic region, hepatitis C, alcohol, NASH, primary biliary cirrhosis, metastasis, and Elixhauser comorbidity score;

³Model is adjusted for age, race, primary payer, hepatitis C, hepatitis B, alcohol, NASH, liver decompensation features, metastasis, and treatment.